Paracetamol overdose in pregnancy analysis of the outcomes of 300 cases referred to the Teratology Information Service.
A prospective study was carried out to investigate the outcome of pregnancy in 300 women who had self-administered an overdose of paracetamol, either alone, or as part of a combined preparation. Exposure occurred in all trimesters. The most striking feature of this study is that the majority of the pregnancies had normal outcomes. Over half of the mothers (160 = 53%) required treatment for the overdose, and 49 of these had specific antidotes (33 mothers had acetylcysteine and 16 mothers had methionine). The rest of the mothers were given nonspecific treatments including ipecacuanha (52), gastric lavage (42), and charcoal (16). None of the mothers died. There were 219 liveborn infants with no malformations, 61 of whom had been exposed in the first trimester. Eleven liveborn infants had malformations; none was exposed in the first trimester. On other infant exposed at 18 weeks had a diaphragmatic hernia; this pregnancy was terminated at 22 weeks. In none of these 12 infants can the malformations be directly associated with paracetamol exposure. There were no apparent differences either in the sex ratio or the body weights of term infants. There were seven full-term infants with neonatal problems that seem unrelated to paracetamol exposure. Six premature infants also had neonatal problems, which were more likely to be related to their degree of prematurity rather than paracetamol exposure. There was no obvious relationship between the time of exposure and the time of delivery. The overall conclusion is that paracetamol overdose per se is not an indication for termination of pregnancy.
McElhatton
P R
PR
Department of Pharmacology & Toxicology, UMDS, St. Thomas' Hospital, London, UK.
Sullivan
F M
FM
Volans
G N
GN
D000082:Acetaminophen / Q000009:adverse effects*; D004346:Drug Information Services; D062787:Drug Overdose; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008131:London; D011039:Poison Control Centers; D011247:Pregnancy; D011256:Pregnancy Outcome; D011297:Prenatal Exposure Delayed Effects; D012017:Referral and Consultation; D013723:Teratogens
D013723:Teratogens; D000082:Acetaminophen